$EOLS Income Statement | Understand Stock

$EOLS

$7.37 +$0.20 (2.79%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product revenue, net
Service revenue
Total revenues
Cost of goods sold
Settlement payment from Daewoong
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
In-process research and development
Revaluation of contingent royalty obligation payable to Evolus Founders
Litigation settlement expenses
Depreciation and amortization
Restructuring costs
Total operating expenses

Loss from operations
Other income (expense):
Interest income
Loss from extinguishment of debts, net
Interest expense
Other income (expense), net

Loss before income taxes
Income tax expense
Net loss
Other comprehensive income (loss), net of tax:
Currency translation adjustment
Comprehensive loss
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Weighted-average shares outstanding used to compute basic net loss per share (in shares)
Weighted-average shares outstanding used to compute diluted net loss per share (in shares)

Comments